BiotechTube
Home/Shattuck Labs/Casi DeYoung
CD

Casi DeYoung

Chief Business Officer

Shattuck Labs

Therapeutic Areas

Inflammatory Bowel DiseaseAutoimmune Diseases

Shattuck Labs Pipeline

DrugIndicationPhase
SL-325Inflammatory Bowel Disease (IBD)Phase 2
SL-425Inflammatory Bowel Disease (IBD)Phase 1
BispecificsAutoimmune DiseasesIND-Enabling

Leadership Team at Shattuck Labs

TH
Taylor H. Schreiber
Chief Executive Officer and Co-founder
LP
Lini Pandite
Chief Medical Officer
AR
Andrew R. Neill
Chief Financial Officer
View full Shattuck Labs profile